From: From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria
Effects on G6PD inhibition activity | |||
---|---|---|---|
G6PD activity in HEP-G2 (% of control, 182 ± 16 nmol/min/mg of protien) | |||
 | 1 μM | 50 μM | 100 μM |
DHEA | 84 ± 7 | 39 ± 6 | 11 ± 2 |
RRx-001 | 78 ± 6 | 16 ± 4 | 6 ± 1 |